{"id":159721,"name":"MYADERM","slug":"myaderm","state":"CO","country":"United States of America","description":"Producer of pharmacist-formulated, transdermal Cannabidiol (CBD) pain creams and topical C","totalSpending":100000,"filings":16,"yearlySpending":[{"year":2019,"income":60000},{"year":2020,"income":40000},{"year":2021,"income":0},{"year":2022,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"PHA","display":"Pharmacy"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["BUCHANAN INGERSOLL & ROONEY PC"],"lobbyists":["TIMOTHY COSTA","MICHAEL STRAZZELLA","ELIZABETH WESTBROOK"],"govEntities":["Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["FDA Policy regarding CBD transdermal pain products","FDA Policy regarding CBD transdermal pain products","FDA Policy regarding CBD transdermal pain products","FDA Policy regarding CBD transdermal pain products","FDA Policy regarding CBD transdermal pain products"]}